Global Orthobiologics Market Growth 2024-2030

December 2024 | 148 pages | ID: G17CA046946DEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Orthobiologics market size was valued at US$ 5174.6 million in 2023. With growing demand in downstream market, the Orthobiologics is forecast to a readjusted size of US$ 7146.3 million by 2030 with a CAGR of 4.7% during review period.

The research report highlights the growth potential of the global Orthobiologics market. Orthobiologics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Orthobiologics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Orthobiologics market.

Key Features:

The report on Orthobiologics market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Orthobiologics market. It may include historical data, market segmentation by Type (e.g., Bone Growth Stimulators (BGS), Viscosupplements), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Orthobiologics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Orthobiologics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Orthobiologics industry. This include advancements in Orthobiologics technology, Orthobiologics new entrants, Orthobiologics new investment, and other innovations that are shaping the future of Orthobiologics.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Orthobiologics market. It includes factors influencing customer ' purchasing decisions, preferences for Orthobiologics product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Orthobiologics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Orthobiologics market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Orthobiologics market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Orthobiologics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Orthobiologics market.

Market Segmentation:

Orthobiologics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Segmentation by type
  • Bone Growth Stimulators (BGS)
  • Viscosupplements
  • Bone Graft Substitute
Segmentation by application
  • Hospitals
  • Ambulatory Surgical Centres
  • Orthopaedics Clinics
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Medtronic
  • NuVasive, Inc.
  • Stryker Corporation
  • Zimmer Biomet Holdings
  • Orthofix International N.V.
  • Anika Therapeutics, Inc.
  • DePuy Synthes (Johnson & Johnson)
  • Bioventus
  • Arthrex, Inc.
  • SeaSpine Holdings Corporation
  • Sanofi-Aventis (Sanofi SA)
  • Djo Global, Inc.
  • Seikagaku Corporation
  • RTI Surgical, Inc.
  • Heraeus Holding GmbH
  • Fidia Pharma USA Inc.
  • TRB Chemedica International SA
  • Allosource
  • Musculoskeletal Transplant Foundation, Inc.
  • Ito
Key Questions Addressed in this Report

What is the 10-year outlook for the global Orthobiologics market?

What factors are driving Orthobiologics market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Orthobiologics market opportunities vary by end market size?

How does Orthobiologics break out type, application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Orthobiologics Annual Sales 2019-2030
  2.1.2 World Current & Future Analysis for Orthobiologics by Geographic Region, 2019, 2023 & 2030
  2.1.3 World Current & Future Analysis for Orthobiologics by Country/Region, 2019, 2023 & 2030
2.2 Orthobiologics Segment by Type
  2.2.1 Bone Growth Stimulators (BGS)
  2.2.2 Viscosupplements
  2.2.3 Bone Graft Substitute
2.3 Orthobiologics Sales by Type
  2.3.1 Global Orthobiologics Sales Market Share by Type (2019-2024)
  2.3.2 Global Orthobiologics Revenue and Market Share by Type (2019-2024)
  2.3.3 Global Orthobiologics Sale Price by Type (2019-2024)
2.4 Orthobiologics Segment by Application
  2.4.1 Hospitals
  2.4.2 Ambulatory Surgical Centres
  2.4.3 Orthopaedics Clinics
2.5 Orthobiologics Sales by Application
  2.5.1 Global Orthobiologics Sale Market Share by Application (2019-2024)
  2.5.2 Global Orthobiologics Revenue and Market Share by Application (2019-2024)
  2.5.3 Global Orthobiologics Sale Price by Application (2019-2024)

3 GLOBAL ORTHOBIOLOGICS BY COMPANY

3.1 Global Orthobiologics Breakdown Data by Company
  3.1.1 Global Orthobiologics Annual Sales by Company (2019-2024)
  3.1.2 Global Orthobiologics Sales Market Share by Company (2019-2024)
3.2 Global Orthobiologics Annual Revenue by Company (2019-2024)
  3.2.1 Global Orthobiologics Revenue by Company (2019-2024)
  3.2.2 Global Orthobiologics Revenue Market Share by Company (2019-2024)
3.3 Global Orthobiologics Sale Price by Company
3.4 Key Manufacturers Orthobiologics Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Orthobiologics Product Location Distribution
  3.4.2 Players Orthobiologics Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR ORTHOBIOLOGICS BY GEOGRAPHIC REGION

4.1 World Historic Orthobiologics Market Size by Geographic Region (2019-2024)
  4.1.1 Global Orthobiologics Annual Sales by Geographic Region (2019-2024)
  4.1.2 Global Orthobiologics Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Orthobiologics Market Size by Country/Region (2019-2024)
  4.2.1 Global Orthobiologics Annual Sales by Country/Region (2019-2024)
  4.2.2 Global Orthobiologics Annual Revenue by Country/Region (2019-2024)
4.3 Americas Orthobiologics Sales Growth
4.4 APAC Orthobiologics Sales Growth
4.5 Europe Orthobiologics Sales Growth
4.6 Middle East & Africa Orthobiologics Sales Growth

5 AMERICAS

5.1 Americas Orthobiologics Sales by Country
  5.1.1 Americas Orthobiologics Sales by Country (2019-2024)
  5.1.2 Americas Orthobiologics Revenue by Country (2019-2024)
5.2 Americas Orthobiologics Sales by Type
5.3 Americas Orthobiologics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Orthobiologics Sales by Region
  6.1.1 APAC Orthobiologics Sales by Region (2019-2024)
  6.1.2 APAC Orthobiologics Revenue by Region (2019-2024)
6.2 APAC Orthobiologics Sales by Type
6.3 APAC Orthobiologics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Orthobiologics by Country
  7.1.1 Europe Orthobiologics Sales by Country (2019-2024)
  7.1.2 Europe Orthobiologics Revenue by Country (2019-2024)
7.2 Europe Orthobiologics Sales by Type
7.3 Europe Orthobiologics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Orthobiologics by Country
  8.1.1 Middle East & Africa Orthobiologics Sales by Country (2019-2024)
  8.1.2 Middle East & Africa Orthobiologics Revenue by Country (2019-2024)
8.2 Middle East & Africa Orthobiologics Sales by Type
8.3 Middle East & Africa Orthobiologics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Orthobiologics
10.3 Manufacturing Process Analysis of Orthobiologics
10.4 Industry Chain Structure of Orthobiologics

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Orthobiologics Distributors
11.3 Orthobiologics Customer

12 WORLD FORECAST REVIEW FOR ORTHOBIOLOGICS BY GEOGRAPHIC REGION

12.1 Global Orthobiologics Market Size Forecast by Region
  12.1.1 Global Orthobiologics Forecast by Region (2025-2030)
  12.1.2 Global Orthobiologics Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Orthobiologics Forecast by Type
12.7 Global Orthobiologics Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Medtronic
  13.1.1 Medtronic Company Information
  13.1.2 Medtronic Orthobiologics Product Portfolios and Specifications
  13.1.3 Medtronic Orthobiologics Sales, Revenue, Price and Gross Margin (2019-2024)
  13.1.4 Medtronic Main Business Overview
  13.1.5 Medtronic Latest Developments
13.2 NuVasive, Inc.
  13.2.1 NuVasive, Inc. Company Information
  13.2.2 NuVasive, Inc. Orthobiologics Product Portfolios and Specifications
  13.2.3 NuVasive, Inc. Orthobiologics Sales, Revenue, Price and Gross Margin (2019-2024)
  13.2.4 NuVasive, Inc. Main Business Overview
  13.2.5 NuVasive, Inc. Latest Developments
13.3 Stryker Corporation
  13.3.1 Stryker Corporation Company Information
  13.3.2 Stryker Corporation Orthobiologics Product Portfolios and Specifications
  13.3.3 Stryker Corporation Orthobiologics Sales, Revenue, Price and Gross Margin (2019-2024)
  13.3.4 Stryker Corporation Main Business Overview
  13.3.5 Stryker Corporation Latest Developments
13.4 Zimmer Biomet Holdings
  13.4.1 Zimmer Biomet Holdings Company Information
  13.4.2 Zimmer Biomet Holdings Orthobiologics Product Portfolios and Specifications
  13.4.3 Zimmer Biomet Holdings Orthobiologics Sales, Revenue, Price and Gross Margin (2019-2024)
  13.4.4 Zimmer Biomet Holdings Main Business Overview
  13.4.5 Zimmer Biomet Holdings Latest Developments
13.5 Orthofix International N.V.
  13.5.1 Orthofix International N.V. Company Information
  13.5.2 Orthofix International N.V. Orthobiologics Product Portfolios and Specifications
  13.5.3 Orthofix International N.V. Orthobiologics Sales, Revenue, Price and Gross Margin (2019-2024)
  13.5.4 Orthofix International N.V. Main Business Overview
  13.5.5 Orthofix International N.V. Latest Developments
13.6 Anika Therapeutics, Inc.
  13.6.1 Anika Therapeutics, Inc. Company Information
  13.6.2 Anika Therapeutics, Inc. Orthobiologics Product Portfolios and Specifications
  13.6.3 Anika Therapeutics, Inc. Orthobiologics Sales, Revenue, Price and Gross Margin (2019-2024)
  13.6.4 Anika Therapeutics, Inc. Main Business Overview
  13.6.5 Anika Therapeutics, Inc. Latest Developments
13.7 DePuy Synthes (Johnson & Johnson)
  13.7.1 DePuy Synthes (Johnson & Johnson) Company Information
  13.7.2 DePuy Synthes (Johnson & Johnson) Orthobiologics Product Portfolios and Specifications
  13.7.3 DePuy Synthes (Johnson & Johnson) Orthobiologics Sales, Revenue, Price and Gross Margin (2019-2024)
  13.7.4 DePuy Synthes (Johnson & Johnson) Main Business Overview
  13.7.5 DePuy Synthes (Johnson & Johnson) Latest Developments
13.8 Bioventus
  13.8.1 Bioventus Company Information
  13.8.2 Bioventus Orthobiologics Product Portfolios and Specifications
  13.8.3 Bioventus Orthobiologics Sales, Revenue, Price and Gross Margin (2019-2024)
  13.8.4 Bioventus Main Business Overview
  13.8.5 Bioventus Latest Developments
13.9 Arthrex, Inc.
  13.9.1 Arthrex, Inc. Company Information
  13.9.2 Arthrex, Inc. Orthobiologics Product Portfolios and Specifications
  13.9.3 Arthrex, Inc. Orthobiologics Sales, Revenue, Price and Gross Margin (2019-2024)
  13.9.4 Arthrex, Inc. Main Business Overview
  13.9.5 Arthrex, Inc. Latest Developments
13.10 SeaSpine Holdings Corporation
  13.10.1 SeaSpine Holdings Corporation Company Information
  13.10.2 SeaSpine Holdings Corporation Orthobiologics Product Portfolios and Specifications
  13.10.3 SeaSpine Holdings Corporation Orthobiologics Sales, Revenue, Price and Gross Margin (2019-2024)
  13.10.4 SeaSpine Holdings Corporation Main Business Overview
  13.10.5 SeaSpine Holdings Corporation Latest Developments
13.11 Sanofi-Aventis (Sanofi SA)
  13.11.1 Sanofi-Aventis (Sanofi SA) Company Information
  13.11.2 Sanofi-Aventis (Sanofi SA) Orthobiologics Product Portfolios and Specifications
  13.11.3 Sanofi-Aventis (Sanofi SA) Orthobiologics Sales, Revenue, Price and Gross Margin (2019-2024)
  13.11.4 Sanofi-Aventis (Sanofi SA) Main Business Overview
  13.11.5 Sanofi-Aventis (Sanofi SA) Latest Developments
13.12 Djo Global, Inc.
  13.12.1 Djo Global, Inc. Company Information
  13.12.2 Djo Global, Inc. Orthobiologics Product Portfolios and Specifications
  13.12.3 Djo Global, Inc. Orthobiologics Sales, Revenue, Price and Gross Margin (2019-2024)
  13.12.4 Djo Global, Inc. Main Business Overview
  13.12.5 Djo Global, Inc. Latest Developments
13.13 Seikagaku Corporation
  13.13.1 Seikagaku Corporation Company Information
  13.13.2 Seikagaku Corporation Orthobiologics Product Portfolios and Specifications
  13.13.3 Seikagaku Corporation Orthobiologics Sales, Revenue, Price and Gross Margin (2019-2024)
  13.13.4 Seikagaku Corporation Main Business Overview
  13.13.5 Seikagaku Corporation Latest Developments
13.14 RTI Surgical, Inc.
  13.14.1 RTI Surgical, Inc. Company Information
  13.14.2 RTI Surgical, Inc. Orthobiologics Product Portfolios and Specifications
  13.14.3 RTI Surgical, Inc. Orthobiologics Sales, Revenue, Price and Gross Margin (2019-2024)
  13.14.4 RTI Surgical, Inc. Main Business Overview
  13.14.5 RTI Surgical, Inc. Latest Developments
13.15 Heraeus Holding GmbH
  13.15.1 Heraeus Holding GmbH Company Information
  13.15.2 Heraeus Holding GmbH Orthobiologics Product Portfolios and Specifications
  13.15.3 Heraeus Holding GmbH Orthobiologics Sales, Revenue, Price and Gross Margin (2019-2024)
  13.15.4 Heraeus Holding GmbH Main Business Overview
  13.15.5 Heraeus Holding GmbH Latest Developments
13.16 Fidia Pharma USA Inc.
  13.16.1 Fidia Pharma USA Inc. Company Information
  13.16.2 Fidia Pharma USA Inc. Orthobiologics Product Portfolios and Specifications
  13.16.3 Fidia Pharma USA Inc. Orthobiologics Sales, Revenue, Price and Gross Margin (2019-2024)
  13.16.4 Fidia Pharma USA Inc. Main Business Overview
  13.16.5 Fidia Pharma USA Inc. Latest Developments
13.17 TRB Chemedica International SA
  13.17.1 TRB Chemedica International SA Company Information
  13.17.2 TRB Chemedica International SA Orthobiologics Product Portfolios and Specifications
  13.17.3 TRB Chemedica International SA Orthobiologics Sales, Revenue, Price and Gross Margin (2019-2024)
  13.17.4 TRB Chemedica International SA Main Business Overview
  13.17.5 TRB Chemedica International SA Latest Developments
13.18 Allosource
  13.18.1 Allosource Company Information
  13.18.2 Allosource Orthobiologics Product Portfolios and Specifications
  13.18.3 Allosource Orthobiologics Sales, Revenue, Price and Gross Margin (2019-2024)
  13.18.4 Allosource Main Business Overview
  13.18.5 Allosource Latest Developments
13.19 Musculoskeletal Transplant Foundation, Inc.
  13.19.1 Musculoskeletal Transplant Foundation, Inc. Company Information
  13.19.2 Musculoskeletal Transplant Foundation, Inc. Orthobiologics Product Portfolios and Specifications
  13.19.3 Musculoskeletal Transplant Foundation, Inc. Orthobiologics Sales, Revenue, Price and Gross Margin (2019-2024)
  13.19.4 Musculoskeletal Transplant Foundation, Inc. Main Business Overview
  13.19.5 Musculoskeletal Transplant Foundation, Inc. Latest Developments
13.20 Ito
  13.20.1 Ito Company Information
  13.20.2 Ito Orthobiologics Product Portfolios and Specifications
  13.20.3 Ito Orthobiologics Sales, Revenue, Price and Gross Margin (2019-2024)
  13.20.4 Ito Main Business Overview
  13.20.5 Ito Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES
.
Table 1. Orthobiologics Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Orthobiologics Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Bone Growth Stimulators (BGS)
Table 4. Major Players of Viscosupplements
Table 5. Major Players of Bone Graft Substitute
Table 6. Global Orthobiologics Sales by Type (2019-2024) & (K Units)
Table 7. Global Orthobiologics Sales Market Share by Type (2019-2024)
Table 8. Global Orthobiologics Revenue by Type (2019-2024) & ($ million)
Table 9. Global Orthobiologics Revenue Market Share by Type (2019-2024)
Table 10. Global Orthobiologics Sale Price by Type (2019-2024) & (USD/Unit)
Table 11. Global Orthobiologics Sales by Application (2019-2024) & (K Units)
Table 12. Global Orthobiologics Sales Market Share by Application (2019-2024)
Table 13. Global Orthobiologics Revenue by Application (2019-2024)
Table 14. Global Orthobiologics Revenue Market Share by Application (2019-2024)
Table 15. Global Orthobiologics Sale Price by Application (2019-2024) & (USD/Unit)
Table 16. Global Orthobiologics Sales by Company (2019-2024) & (K Units)
Table 17. Global Orthobiologics Sales Market Share by Company (2019-2024)
Table 18. Global Orthobiologics Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Orthobiologics Revenue Market Share by Company (2019-2024)
Table 20. Global Orthobiologics Sale Price by Company (2019-2024) & (USD/Unit)
Table 21. Key Manufacturers Orthobiologics Producing Area Distribution and Sales Area
Table 22. Players Orthobiologics Products Offered
Table 23. Orthobiologics Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Orthobiologics Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Orthobiologics Sales Market Share Geographic Region (2019-2024)
Table 28. Global Orthobiologics Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Orthobiologics Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Orthobiologics Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Orthobiologics Sales Market Share by Country/Region (2019-2024)
Table 32. Global Orthobiologics Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Orthobiologics Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Orthobiologics Sales by Country (2019-2024) & (K Units)
Table 35. Americas Orthobiologics Sales Market Share by Country (2019-2024)
Table 36. Americas Orthobiologics Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Orthobiologics Revenue Market Share by Country (2019-2024)
Table 38. Americas Orthobiologics Sales by Type (2019-2024) & (K Units)
Table 39. Americas Orthobiologics Sales by Application (2019-2024) & (K Units)
Table 40. APAC Orthobiologics Sales by Region (2019-2024) & (K Units)
Table 41. APAC Orthobiologics Sales Market Share by Region (2019-2024)
Table 42. APAC Orthobiologics Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Orthobiologics Revenue Market Share by Region (2019-2024)
Table 44. APAC Orthobiologics Sales by Type (2019-2024) & (K Units)
Table 45. APAC Orthobiologics Sales by Application (2019-2024) & (K Units)
Table 46. Europe Orthobiologics Sales by Country (2019-2024) & (K Units)
Table 47. Europe Orthobiologics Sales Market Share by Country (2019-2024)
Table 48. Europe Orthobiologics Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Orthobiologics Revenue Market Share by Country (2019-2024)
Table 50. Europe Orthobiologics Sales by Type (2019-2024) & (K Units)
Table 51. Europe Orthobiologics Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Orthobiologics Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Orthobiologics Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Orthobiologics Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Orthobiologics Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Orthobiologics Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Orthobiologics Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Orthobiologics
Table 59. Key Market Challenges & Risks of Orthobiologics
Table 60. Key Industry Trends of Orthobiologics
Table 61. Orthobiologics Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Orthobiologics Distributors List
Table 64. Orthobiologics Customer List
Table 65. Global Orthobiologics Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Orthobiologics Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Orthobiologics Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Orthobiologics Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Orthobiologics Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Orthobiologics Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Orthobiologics Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Orthobiologics Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Orthobiologics Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Orthobiologics Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Orthobiologics Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Orthobiologics Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Orthobiologics Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Orthobiologics Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Medtronic Basic Information, Orthobiologics Manufacturing Base, Sales Area and Its Competitors
Table 80. Medtronic Orthobiologics Product Portfolios and Specifications
Table 81. Medtronic Orthobiologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Medtronic Main Business
Table 83. Medtronic Latest Developments
Table 84. NuVasive, Inc. Basic Information, Orthobiologics Manufacturing Base, Sales Area and Its Competitors
Table 85. NuVasive, Inc. Orthobiologics Product Portfolios and Specifications
Table 86. NuVasive, Inc. Orthobiologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. NuVasive, Inc. Main Business
Table 88. NuVasive, Inc. Latest Developments
Table 89. Stryker Corporation Basic Information, Orthobiologics Manufacturing Base, Sales Area and Its Competitors
Table 90. Stryker Corporation Orthobiologics Product Portfolios and Specifications
Table 91. Stryker Corporation Orthobiologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Stryker Corporation Main Business
Table 93. Stryker Corporation Latest Developments
Table 94. Zimmer Biomet Holdings Basic Information, Orthobiologics Manufacturing Base, Sales Area and Its Competitors
Table 95. Zimmer Biomet Holdings Orthobiologics Product Portfolios and Specifications
Table 96. Zimmer Biomet Holdings Orthobiologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Zimmer Biomet Holdings Main Business
Table 98. Zimmer Biomet Holdings Latest Developments
Table 99. Orthofix International N.V. Basic Information, Orthobiologics Manufacturing Base, Sales Area and Its Competitors
Table 100. Orthofix International N.V. Orthobiologics Product Portfolios and Specifications
Table 101. Orthofix International N.V. Orthobiologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Orthofix International N.V. Main Business
Table 103. Orthofix International N.V. Latest Developments
Table 104. Anika Therapeutics, Inc. Basic Information, Orthobiologics Manufacturing Base, Sales Area and Its Competitors
Table 105. Anika Therapeutics, Inc. Orthobiologics Product Portfolios and Specifications
Table 106. Anika Therapeutics, Inc. Orthobiologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Anika Therapeutics, Inc. Main Business
Table 108. Anika Therapeutics, Inc. Latest Developments
Table 109. DePuy Synthes (Johnson & Johnson) Basic Information, Orthobiologics Manufacturing Base, Sales Area and Its Competitors
Table 110. DePuy Synthes (Johnson & Johnson) Orthobiologics Product Portfolios and Specifications
Table 111. DePuy Synthes (Johnson & Johnson) Orthobiologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. DePuy Synthes (Johnson & Johnson) Main Business
Table 113. DePuy Synthes (Johnson & Johnson) Latest Developments
Table 114. Bioventus Basic Information, Orthobiologics Manufacturing Base, Sales Area and Its Competitors
Table 115. Bioventus Orthobiologics Product Portfolios and Specifications
Table 116. Bioventus Orthobiologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. Bioventus Main Business
Table 118. Bioventus Latest Developments
Table 119. Arthrex, Inc. Basic Information, Orthobiologics Manufacturing Base, Sales Area and Its Competitors
Table 120. Arthrex, Inc. Orthobiologics Product Portfolios and Specifications
Table 121. Arthrex, Inc. Orthobiologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. Arthrex, Inc. Main Business
Table 123. Arthrex, Inc. Latest Developments
Table 124. SeaSpine Holdings Corporation Basic Information, Orthobiologics Manufacturing Base, Sales Area and Its Competitors
Table 125. SeaSpine Holdings Corporation Orthobiologics Product Portfolios and Specifications
Table 126. SeaSpine Holdings Corporation Orthobiologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 127. SeaSpine Holdings Corporation Main Business
Table 128. SeaSpine Holdings Corporation Latest Developments
Table 129. Sanofi-Aventis (Sanofi SA) Basic Information, Orthobiologics Manufacturing Base, Sales Area and Its Competitors
Table 130. Sanofi-Aventis (Sanofi SA) Orthobiologics Product Portfolios and Specifications
Table 131. Sanofi-Aventis (Sanofi SA) Orthobiologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 132. Sanofi-Aventis (Sanofi SA) Main Business
Table 133. Sanofi-Aventis (Sanofi SA) Latest Developments
Table 134. Djo Global, Inc. Basic Information, Orthobiologics Manufacturing Base, Sales Area and Its Competitors
Table 135. Djo Global, Inc. Orthobiologics Product Portfolios and Specifications
Table 136. Djo Global, Inc. Orthobiologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 137. Djo Global, Inc. Main Business
Table 138. Djo Global, Inc. Latest Developments
Table 139. Seikagaku Corporation Basic Information, Orthobiologics Manufacturing Base, Sales Area and Its Competitors
Table 140. Seikagaku Corporation Orthobiologics Product Portfolios and Specifications
Table 141. Seikagaku Corporation Orthobiologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 142. Seikagaku Corporation Main Business
Table 143. Seikagaku Corporation Latest Developments
Table 144. RTI Surgical, Inc. Basic Information, Orthobiologics Manufacturing Base, Sales Area and Its Competitors
Table 145. RTI Surgical, Inc. Orthobiologics Product Portfolios and Specifications
Table 146. RTI Surgical, Inc. Orthobiologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 147. RTI Surgical, Inc. Main Business
Table 148. RTI Surgical, Inc. Latest Developments
Table 149. Heraeus Holding GmbH Basic Information, Orthobiologics Manufacturing Base, Sales Area and Its Competitors
Table 150. Heraeus Holding GmbH Orthobiologics Product Portfolios and Specifications
Table 151. Heraeus Holding GmbH Orthobiologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 152. Heraeus Holding GmbH Main Business
Table 153. Heraeus Holding GmbH Latest Developments
Table 154. Fidia Pharma USA Inc. Basic Information, Orthobiologics Manufacturing Base, Sales Area and Its Competitors
Table 155. Fidia Pharma USA Inc. Orthobiologics Product Portfolios and Specifications
Table 156. Fidia Pharma USA Inc. Orthobiologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 157. Fidia Pharma USA Inc. Main Business
Table 158. Fidia Pharma USA Inc. Latest Developments
Table 159. TRB Chemedica International SA Basic Information, Orthobiologics Manufacturing Base, Sales Area and Its Competitors
Table 160. TRB Chemedica International SA Orthobiologics Product Portfolios and Specifications
Table 161. TRB Chemedica International SA Orthobiologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 162. TRB Chemedica International SA Main Business
Table 163. TRB Chemedica International SA Latest Developments
Table 164. Allosource Basic Information, Orthobiologics Manufacturing Base, Sales Area and Its Competitors
Table 165. Allosource Orthobiologics Product Portfolios and Specifications
Table 166. Allosource Orthobiologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 167. Allosource Main Business
Table 168. Allosource Latest Developments
Table 169. Musculoskeletal Transplant Foundation, Inc. Basic Information, Orthobiologics Manufacturing Base, Sales Area and Its Competitors
Table 170. Musculoskeletal Transplant Foundation, Inc. Orthobiologics Product Portfolios and Specifications
Table 171. Musculoskeletal Transplant Foundation, Inc. Orthobiologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 172. Musculoskeletal Transplant Foundation, Inc. Main Business
Table 173. Musculoskeletal Transplant Foundation, Inc. Latest Developments
Table 174. Ito Basic Information, Orthobiologics Manufacturing Base, Sales Area and Its Competitors
Table 175. Ito Orthobiologics Product Portfolios and Specifications
Table 176. Ito Orthobiologics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 177. Ito Main Business
Table 178. Ito Latest Developments

LIST OF FIGURES
.
Figure 1. Picture of Orthobiologics
Figure 2. Orthobiologics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Orthobiologics Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Orthobiologics Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Orthobiologics Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Bone Growth Stimulators (BGS)
Figure 10. Product Picture of Viscosupplements
Figure 11. Product Picture of Bone Graft Substitute
Figure 12. Global Orthobiologics Sales Market Share by Type in 2023
Figure 13. Global Orthobiologics Revenue Market Share by Type (2019-2024)
Figure 14. Orthobiologics Consumed in Hospitals
Figure 15. Global Orthobiologics Market: Hospitals (2019-2024) & (K Units)
Figure 16. Orthobiologics Consumed in Ambulatory Surgical Centres
Figure 17. Global Orthobiologics Market: Ambulatory Surgical Centres (2019-2024) & (K Units)
Figure 18. Orthobiologics Consumed in Orthopaedics Clinics
Figure 19. Global Orthobiologics Market: Orthopaedics Clinics (2019-2024) & (K Units)
Figure 20. Global Orthobiologics Sales Market Share by Application (2023)
Figure 21. Global Orthobiologics Revenue Market Share by Application in 2023
Figure 22. Orthobiologics Sales Market by Company in 2023 (K Units)
Figure 23. Global Orthobiologics Sales Market Share by Company in 2023
Figure 24. Orthobiologics Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Orthobiologics Revenue Market Share by Company in 2023
Figure 26. Global Orthobiologics Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Orthobiologics Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Orthobiologics Sales 2019-2024 (K Units)
Figure 29. Americas Orthobiologics Revenue 2019-2024 ($ Millions)
Figure 30. APAC Orthobiologics Sales 2019-2024 (K Units)
Figure 31. APAC Orthobiologics Revenue 2019-2024 ($ Millions)
Figure 32. Europe Orthobiologics Sales 2019-2024 (K Units)
Figure 33. Europe Orthobiologics Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Orthobiologics Sales 2019-2024 (K Units)
Figure 35. Middle East & Africa Orthobiologics Revenue 2019-2024 ($ Millions)
Figure 36. Americas Orthobiologics Sales Market Share by Country in 2023
Figure 37. Americas Orthobiologics Revenue Market Share by Country in 2023
Figure 38. Americas Orthobiologics Sales Market Share by Type (2019-2024)
Figure 39. Americas Orthobiologics Sales Market Share by Application (2019-2024)
Figure 40. United States Orthobiologics Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Orthobiologics Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Orthobiologics Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Orthobiologics Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Orthobiologics Sales Market Share by Region in 2023
Figure 45. APAC Orthobiologics Revenue Market Share by Regions in 2023
Figure 46. APAC Orthobiologics Sales Market Share by Type (2019-2024)
Figure 47. APAC Orthobiologics Sales Market Share by Application (2019-2024)
Figure 48. China Orthobiologics Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Orthobiologics Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Orthobiologics Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Orthobiologics Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Orthobiologics Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Orthobiologics Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Orthobiologics Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Orthobiologics Sales Market Share by Country in 2023
Figure 56. Europe Orthobiologics Revenue Market Share by Country in 2023
Figure 57. Europe Orthobiologics Sales Market Share by Type (2019-2024)
Figure 58. Europe Orthobiologics Sales Market Share by Application (2019-2024)
Figure 59. Germany Orthobiologics Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Orthobiologics Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Orthobiologics Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Orthobiologics Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Orthobiologics Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Orthobiologics Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Orthobiologics Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Orthobiologics Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Orthobiologics Sales Market Share by Application (2019-2024)
Figure 68. Egypt Orthobiologics Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Orthobiologics Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Orthobiologics Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Orthobiologics Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Orthobiologics Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Orthobiologics in 2023
Figure 74. Manufacturing Process Analysis of Orthobiologics
Figure 75. Industry Chain Structure of Orthobiologics
Figure 76. Channels of Distribution
Figure 77. Global Orthobiologics Sales Market Forecast by Region (2025-2030)
Figure 78. Global Orthobiologics Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Orthobiologics Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Orthobiologics Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Orthobiologics Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Orthobiologics Revenue Market Share Forecast by Application (2025-2030)